{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,26]],"date-time":"2026-04-26T00:32:59Z","timestamp":1777163579470,"version":"3.51.4"},"reference-count":44,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","aaojournal.org","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1016\/j.ophtha.2018.01.032","type":"journal-article","created":{"date-parts":[[2018,3,2]],"date-time":"2018-03-02T15:32:47Z","timestamp":1520004767000},"page":"747-754","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Clinical Predictors of Regression of Choroidal Melanomas after Brachytherapy"],"prefix":"10.1016","volume":"125","author":[{"given":"Mamunur","family":"Rashid","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jorma","family":"Heikkonen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arun D.","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tero T.","family":"Kivel\u00e4","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ophtha.2018.01.032_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.brachy.2013.11.008","article-title":"The American Brachytherapy Society consensus guidelines for plaque brachytherapy of uveal melanoma and retinoblastoma","volume":"13","year":"2014","journal-title":"Brachytherapy"},{"key":"10.1016\/j.ophtha.2018.01.032_bib2","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1001\/archopht.124.12.1684","article-title":"The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma: V. Twelve-year mortality rates and prognostic factors: COMS report no. 28","volume":"124","year":"2006","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2018.01.032_bib3","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1046\/j.1442-9071.2000.00354.x","article-title":"Iodine-I25 episcleral plaque therapy in uveal melanoma","volume":"28","author":"Sia","year":"2000","journal-title":"Clin Exp Ophthalmol"},{"key":"10.1016\/j.ophtha.2018.01.032_bib4","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.1016\/j.ophtha.2013.04.017","article-title":"Palladium-103 radiation therapy for small choroidal melanoma","volume":"120","author":"Semenova","year":"2013","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2018.01.032_bib5","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1001\/jamaophthalmol.2013.5677","article-title":"Palladium-103 plaque radiation therapy for American Joint Committee on Cancer T3- and T4-staged choroidal melanomas","volume":"132","author":"Semenova","year":"2014","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.ophtha.2018.01.032_bib6","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1136\/bjo.2003.036285","article-title":"Post-brachytherapy initial tumour regression rate correlates with metastatic spread in posterior uveal melanoma","volume":"88","author":"Kaiserman","year":"2004","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ophtha.2018.01.032_bib7","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1136\/bjophthalmol-2012-302584","article-title":"Prognosis of choroidal melanoma and the result of ruthenium brachytherapy combined with transpupillary thermotherapy in Korean patients","volume":"97","author":"Kwon","year":"2013","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ophtha.2018.01.032_bib8","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.radonc.2010.03.023","article-title":"Long-term outcomes of eye-conserving treatment with ruthenium106 brachytherapy for choroidal melanoma","volume":"95","author":"Verschueren","year":"2010","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ophtha.2018.01.032_bib9","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1136\/bjo.2009.176198","article-title":"Predicting local control of choroidal melanomas following 106Ru plaque brachytherapy","volume":"95","author":"Papageorgiou","year":"2011","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ophtha.2018.01.032_bib10","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1136\/bjophthalmol-2013-304472","article-title":"Does choroidal melanoma regression correlate with chromosome 3 loss after ruthenium brachytherapy?","volume":"98","author":"Chiam","year":"2014","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ophtha.2018.01.032_bib11","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1136\/bjophthalmol-2014-305055","article-title":"High dose rate and low dose rate ruthenium brachytherapy for uveal melanoma. No association with ocular outcome","volume":"98","author":"Fili","year":"2014","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ophtha.2018.01.032_bib12","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.brachy.2012.01.012","article-title":"Tumor control, eye preservation, and visual outcomes of ruthenium plaque brachytherapy for choroidal melanoma","volume":"12","author":"Marconi","year":"2013","journal-title":"Brachytherapy"},{"key":"10.1016\/j.ophtha.2018.01.032_bib13","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1016\/S0161-6420(03)00661-4","article-title":"Iodine brachytherapy as an alternative to enucleation for large uveal melanomas","volume":"110","author":"Puusaari","year":"2003","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2018.01.032_bib14","doi-asserted-by":"crossref","first-page":"e169","DOI":"10.1016\/j.prro.2014.09.005","article-title":"A\u00a0choice of radionuclide: comparative outcomes and toxicity of ruthenium-106 and iodine-125 in the definitive treatment of uveal melanoma","volume":"5","author":"Takiar","year":"2015","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.ophtha.2018.01.032_bib15","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1097\/IAE.0000000000000202","article-title":"Management of choroidal melanomas less than 10 mm in largest basal diameter with a 10-mm ruthenium plaque","volume":"34","author":"Salkola","year":"2014","journal-title":"Retina"},{"key":"10.1016\/j.ophtha.2018.01.032_bib16","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/S0161-6420(87)33310-X","article-title":"Post-irradiation regression of choroidal melanomas as a risk factor for death from metastatic disease","volume":"94","author":"Augsburger","year":"1987","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2018.01.032_bib17","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1016\/S0161-6420(89)32685-6","article-title":"Evaluation of tumor regression and other prognostic factors for early and late metastasis after proton irradiation of uveal melanoma","volume":"96","author":"Glynn","year":"1989","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2018.01.032_bib18","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1055\/s-2008-1046119","article-title":"Das Regressionsverhalten des Aderhautmelanoms nach Strahlentherapie\u2212ein neuer prognostischer Parameter?","volume":"196","author":"Guthoff","year":"1990","journal-title":"Klin Monatsbl Augenheilkd"},{"key":"10.1016\/j.ophtha.2018.01.032_bib19","doi-asserted-by":"crossref","first-page":"103","DOI":"10.4103\/0974-9233.148358","article-title":"Regression rate of posterior uveal melanomas following iodine-125 plaque radiotherapy","volume":"22","author":"Demirci","year":"2015","journal-title":"Middle East Afr J Ophthalmol"},{"key":"10.1016\/j.ophtha.2018.01.032_bib20","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1016\/S0161-6420(84)34087-8","article-title":"Regression of posterior uveal melanomas following cobalt-60 plaque radiotherapy","volume":"91","author":"Cruess","year":"1984","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2018.01.032_bib21","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1055\/s-2003-812561","article-title":"Echographic follow-up of malignant melanoma of the choroid after brachytherapy with 106Ru","volume":"220","author":"Novak-Andrej\u010di\u010d","year":"2003","journal-title":"Klin Monatsbl Augenheilkd"},{"key":"10.1016\/j.ophtha.2018.01.032_bib22","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1097\/IAE.0b013e31817f7b3e","article-title":"Regression of uveal melanoma after plaque radiotherapy and thermotherapy based on chromosome 3 status","volume":"28","author":"Shields","year":"2008","journal-title":"Retina"},{"key":"10.1016\/j.ophtha.2018.01.032_bib23","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1016\/j.ijrobp.2010.07.016","article-title":"Ocular response of choroidal melanoma with monosomy 3 versus disomy 3 after iodine-125 brachytherapy","volume":"81","author":"Marathe","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ophtha.2018.01.032_bib24","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.ajo.2012.02.022","article-title":"Uveal melanoma: molecular pattern, clinical features, and radiation response","volume":"154","author":"Chappell","year":"2012","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2018.01.032_bib25","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1167\/iovs.13-13381","article-title":"Relationship between rate of posterior uveal melanoma flattening following plaque radiotherapy and gene expression profile class of tumor cells","volume":"55","author":"Corr\u00eaa","year":"2014","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ophtha.2018.01.032_bib26","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1007\/s00417-016-3305-2","article-title":"Tumor-height regression rate after brachytherapy between choroidal melanoma gene expression profile classes: effect of controlling for tumor height","volume":"254","author":"Gupta","year":"2016","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.ophtha.2018.01.032_bib27","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1016\/j.ophtha.2017.04.013","article-title":"Association between tumor regression rate and gene expression profile after Iodine 125 plaque radiotherapy for uveal melanoma","volume":"124","author":"Mruthyunjaya","year":"2017","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2018.01.032_bib28","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1159\/000451001","article-title":"Uveal melanoma regression after brachytherapy: relationship with chromosome 3 monosomy status","volume":"3","author":"Salvi","year":"2017","journal-title":"Ocul Oncol Pathol"},{"key":"10.1016\/j.ophtha.2018.01.032_bib29","doi-asserted-by":"crossref","first-page":"333","DOI":"10.3928\/23258160-20150323-06","article-title":"Gene expression profiling and regression rate of irradiated uveal melanomas","volume":"46","author":"Rao","year":"2015","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"key":"10.1016\/j.ophtha.2018.01.032_bib30","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.jcjo.2013.09.007","article-title":"Quantitative echography in primary uveal melanoma treated by proton beam therapy","volume":"49","author":"Mosci","year":"2014","journal-title":"Can J Ophthalmol"},{"key":"10.1016\/j.ophtha.2018.01.032_bib31","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/BF02173352","article-title":"Regression of posterior uveal malignant melanomas after cobalt plaque radiotherapy","volume":"224","author":"Augsburger","year":"1986","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.ophtha.2018.01.032_bib32","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1136\/bjo.74.6.359","article-title":"Changes in height of choroidal melanomas after plaque therapy","volume":"74","author":"Abramson","year":"1990","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ophtha.2018.01.032_bib33","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1016\/S0161-6420(02)01054-0","article-title":"Changes in ultrasound findings in posterior uveal melanoma after ruthenium 106 brachytherapy","volume":"109","author":"Kaiserman","year":"2002","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2018.01.032_bib34","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1097\/IAE.0b013e31829479fb","article-title":"Regression of uveal melanoma after Ru-106 brachytherapy and thermotherapy based on metabolic activity measured by positron emission tomography\/computed tomography","volume":"34","author":"Lee","year":"2014","journal-title":"Retina"},{"key":"10.1016\/j.ophtha.2018.01.032_bib35","first-page":"193","article-title":"Intravitreal bevacizumab combined with plaque brachytherapy reduces melanoma tumor volume and enhances resolution of exudative detachment","volume":"7","author":"Houston","year":"2013","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.ophtha.2018.01.032_bib36","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1167\/iovs.14-16322","article-title":"Tumor regression after brachytherapy for choroidal melanoma: reduction of thickness and cross-sectional area by shape and regression pattern","volume":"56","author":"Rashid","year":"2015","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ophtha.2018.01.032_bib37","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1001\/archopht.1997.01100150476004","article-title":"Comparison of transillumination and histologic slide measurements of choroidal melanoma","volume":"115","author":"Umlas","year":"1997","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2018.01.032_bib38","doi-asserted-by":"crossref","first-page":"2825","DOI":"10.1200\/JCO.2012.45.2771","article-title":"Staging of ciliary body and choroidal melanomas based on anatomic extent","volume":"31","author":"Kujala","year":"2013","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.ophtha.2018.01.032_bib39","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1016\/j.ophtha.2004.03.027","article-title":"Ocular complications after iodine brachytherapy for large ciliochoroidal melanomas","volume":"111","author":"Puusaari","year":"2004","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2018.01.032_bib40","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1002\/sim.4780040112","article-title":"Wilcoxon-type test for trend","volume":"4","author":"Cuzick","year":"1985","journal-title":"Stat Med"},{"key":"10.1016\/j.ophtha.2018.01.032_bib41","series-title":"Multilevel and Longitudinal Modeling using Stata Volume I: Continuous Responses","first-page":"343","article-title":"Growth-curve models","author":"Rabe-Hesketh","year":"2012"},{"key":"10.1016\/j.ophtha.2018.01.032_bib42","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/eye.2012.241","article-title":"Radiotherapy for ocular tumours","volume":"27","author":"Stannard","year":"2013","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.ophtha.2018.01.032_bib43","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.ophtha.2005.10.059","article-title":"Pigmented episcleral deposits after brachytherapy of uveal melanoma","volume":"113","author":"Toivonen","year":"2006","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2018.01.032_bib44","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1111\/j.1755-3768.2010.01985.x","article-title":"Infiltrating macrophages in extratumoural tissues after brachytherapy of uveal melanoma","volume":"90","author":"Toivonen","year":"2012","journal-title":"Acta Ophthalmol"}],"container-title":["Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642017332529?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642017332529?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,7,24]],"date-time":"2018-07-24T08:52:33Z","timestamp":1532422353000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161642017332529"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":44,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,5]]}},"alternative-id":["S0161642017332529"],"URL":"https:\/\/doi.org\/10.1016\/j.ophtha.2018.01.032","relation":{},"ISSN":["0161-6420"],"issn-type":[{"value":"0161-6420","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical Predictors of Regression of Choroidal Melanomas after Brachytherapy","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ophtha.2018.01.032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 by the American Academy of Ophthalmology","name":"copyright","label":"Copyright"}]}}